This inventor holds 2 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignees: Institut Pasteur De Lille, National Institute of Health and Medical Research, Universite De Droit Et De Sante De Lille. Active years: 2018-2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Châtillon, FR (2018)
- Lille, FR (2019)
Company Filing History:
2 out of 65 
2 out of 1,853 
1 out of 1 
Years Active: 2018-2019
Title: The Innovative Contributions of Sara Sofia Gonzalez-Hilarion
Introduction
Sara Sofia Gonzalez-Hilarion is a prominent inventor based in Lille, France. She has made significant strides in the field of medical research, particularly in the treatment of genetic diseases. With a total of 2 patents to her name, her work is paving the way for advancements in pharmaceutical compositions.
Latest Patents
Gonzalez-Hilarion's latest patents include a compound useful for the treatment of nonsense-mutation-mediated diseases. This invention relates to a compound of formula (I) that is designed for use in treating genetic diseases caused by nonsense mutations. Her innovative approach aims to provide effective solutions for patients suffering from these conditions.
Career Highlights
Throughout her career, Gonzalez-Hilarion has worked with esteemed institutions such as the Institut National de la Santé et de la Recherche Médicale and the Institut Pasteur de Lille. These experiences have allowed her to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Some of her notable coworkers include Fabrice Lejeune and Benoit Deprez. Their collaborative efforts have further enhanced the impact of her research and inventions.
Conclusion
Sara Sofia Gonzalez-Hilarion's contributions to medical research and her innovative patents highlight her dedication to improving healthcare solutions. Her work continues to inspire future advancements in the treatment of genetic diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile